FeNO was normalized and IgE strongly reduced.<h4>Conclusion</h4>Our case highlights that a patient may exhibit differential treatment responses to the currently available asthma biologics and suggests switching treatment if outcome is insufficient. This evidence concerns the gene IGHE and asthma.